Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SVS20 for moderate bilateral dry eye syndrome
ISRCTN91412460Phase 3Completed
- Sponsor
- TRB Chemedica
- Start
- Oct 2007
- Modality
- Recombinant Proteins and Enzymes, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
01
Overview
Phase 3 trial of SVS20, sodium hyaluronate, saline and carbomer, sponsored by TRB Chemedica. Started Oct 2007; status: completed.
02
Drugs
SVS20sodium hyaluronatesalinecarbomer
Beyond the preview
Go deeper on ISRCTN91412460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN91412460.